Literature DB >> 33362262

Community-setting pneumonia-associated hospitalizations by level of urbanization-New York City versus other areas of New York State, 2010-2014.

Melody Wu1,2, Katherine Whittemore2, Chaorui C Huang2, Rachel E Corrado2, Gretchen M Culp3, Sungwoo Lim3, Neil W Schluger4,5, Demetre C Daskalakis2, David E Lucero2, Neil M Vora2,6.   

Abstract

BACKGROUND: New York City (NYC) reported a higher pneumonia and influenza death rate than the rest of New York State during 2010-2014. Most NYC pneumonia and influenza deaths are attributed to pneumonia caused by infection acquired in the community, and these deaths typically occur in hospitals.
METHODS: We identified hospitalizations of New York State residents aged ≥20 years discharged from New York State hospitals during 2010-2014 with a principal diagnosis of community-setting pneumonia or a secondary diagnosis of community-setting pneumonia if the principal diagnosis was respiratory failure or sepsis. We examined mean annual age-adjusted community-setting pneumonia-associated hospitalization (CSPAH) rates and proportion of CSPAH with in-hospital death, overall and by sociodemographic group, and produced a multivariable negative binomial model to assess hospitalization rate ratios.
RESULTS: Compared with non-NYC urban, suburban, and rural areas of New York State, NYC had the highest mean annual age-adjusted CSPAH rate at 475.3 per 100,000 population and the highest percentage of CSPAH with in-hospital death at 13.7%. NYC also had the highest proportion of CSPAH patients residing in higher-poverty-level areas. Adjusting for age, sex, and area-based poverty, NYC residents experienced 1.3 (95% confidence interval [CI], 1.2-1.4), non-NYC urban residents 1.4 (95% CI, 1.3-1.6), and suburban residents 1.2 (95% CI, 1.1-1.3) times the rate of CSPAH than rural residents.
CONCLUSIONS: In New York State, NYC as well as other urban areas and suburban areas had higher rates of CSPAH than rural areas. Further research is needed into drivers of CSPAH deaths, which may be associated with poverty.

Entities:  

Year:  2020        PMID: 33362262      PMCID: PMC7757877          DOI: 10.1371/journal.pone.0244367

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  24 in total

1.  Age adjustment using the 2000 projected U.S. population.

Authors:  R J Klein; C A Schoenborn
Journal:  Healthy People 2010 Stat Notes       Date:  2001-01

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

3.  Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.

Authors:  Alan E Gross; Trevor C Van Schooneveld; Keith M Olsen; Mark E Rupp; Thu Hong Bui; Elsie Forsung; Andre C Kalil
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

Review 4.  Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review.

Authors:  Linda Calvillo-King; Danielle Arnold; Kathryn J Eubank; Matthew Lo; Pete Yunyongying; Heather Stieglitz; Ethan A Halm
Journal:  J Gen Intern Med       Date:  2012-10-06       Impact factor: 5.128

5.  A comparison of quality of care indicators in urban acute care hospitals and rural critical access hospitals in the United States.

Authors:  M Nawal Lutfiyya; Deepa K Bhat; Seema R Gandhi; Catherine Nguyen; Vicki L Weidenbacher-Hoper; Martin S Lipsky
Journal:  Int J Qual Health Care       Date:  2007-04-18       Impact factor: 2.038

6.  The County Health Rankings: rationale and methods.

Authors:  Patrick L Remington; Bridget B Catlin; Keith P Gennuso
Journal:  Popul Health Metr       Date:  2015-04-17

7.  Space-time analysis of pneumonia hospitalisations in the Netherlands.

Authors:  Elisa Benincà; Michiel van Boven; Thomas Hagenaars; Wim van der Hoek
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

8.  Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.

Authors:  Joshua P Metlay; Grant W Waterer; Ann C Long; Antonio Anzueto; Jan Brozek; Kristina Crothers; Laura A Cooley; Nathan C Dean; Michael J Fine; Scott A Flanders; Marie R Griffin; Mark L Metersky; Daniel M Musher; Marcos I Restrepo; Cynthia G Whitney
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

9.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

Review 10.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Authors:  Antoni Torres; Francesco Blasi; Nathalie Dartois; Murat Akova
Journal:  Thorax       Date:  2015-07-28       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.